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eply
e thank Dr. Di Bella and colleagues for their comments on our
aper (1). With a number of qualifications, we concur. Shared
orphology is an important but not the sole reason for misattribution
f left-dominant arrhythmogenic cardiomyopathy (LDAC). In our
tudy, 4 patients had prior diagnoses of idiopathic ventricular
achycardia/benign ventricular ectopy because investigation had
een terminated on acquisition of a normal echocardiogram and
oronary angiogram, with consequent failure to identify the myo-
ardial substrate (1).
Among their examples of “other cardiomyopathies” that show
orphological overlap with LDAC, Dr. Di Bella and colleagues
ite biventricular arrhythmogenic cardiomyopathy. Because both
re under-recognized subtypes of the same disease, similarities are
xpected. The proposed 3-way classification of arrhythmogenic
ardiomyopathy (2) is simplistic; the reality is probably a contin-
um, at opposite ends of which lie the classic right- and left-
ominant forms. Whether differentiating between left-dominant
nd biventricular subtypes is of clinical importance will depend on
ts bearing, if any, on management and outcomes. Evidence of
ignificant differences in prognosis from follow-up studies will
arrant clearer guidelines for subtype designation.
Of unequivocal clinical relevance is the distinction between
ilated cardiomyopathy (DCM) and arrhythmogenic cardiomyop-
thy, regardless of subtype (1). Contrary to the assertion of Dr. Di
ella and colleagues, we have not advocated seeking “prominent
ight ventricular abnormalities added with left ventricular involve-
ent.” In this context, having excluded ischemic heart disease and
ther confounders, we noted that localized morphological changes
avor a diagnosis of arrhythmogenic cardiomyopathy, and are
requently right-sided, even in LDAC (1). No structural feature,
owever, is specific to arrhythmogenic cardiomyopathy. Right
entricular aneurysms are observed in cardiac sarcoidosis and, as
r. Di Bella and colleagues indicate, lipomatous metaplasia and
ubepicardial late enhancement occur in a variety of disorders.
or these reasons, clinical diagnosis of arrhythmogenic cardio-
yopathy is based on a combination of different criteria, never
n morphological abnormalities alone (3), and clinical context is
ey. Dr. Di Bella and colleagues omit that LDAC is distin-
uished from DCM primarily on clinical grounds, by recogniz-
ng arrhythmogenicity exceeding the degree of morphological
bnormality and systolic impairment (1). Thus, DCM presents
ith clinical heart failure, whereas arrhythmia is foremost in the
ymptomatology of LDAC. Morphological differences serve as a
inor aid.
Fontaine and Fornès (4) have suggested that LDAC results
rom superimposition of chronic myocarditis on classic arrhyth-
ogenic cardiomyopathy. Mice expressing C-terminal mutationsn desmoplakin show early and prominent left ventricular dysfunc-
ion, suggesting that the genetic defect per se is a major determi-
ant of phenotype (5). To reconcile the genetic basis of LDAC
ith a putative viral etiology, Dr. Di Bella and colleagues invoke
nhanced susceptibility of the diseased myocardium to infection, as
reviously observed in dystrophin-deficient mice (6). Available
ata neither support nor exclude this mechanism in arrhyth-
ogenic cardiomyopathy. In existing studies of the classic subtype,
he prevalence of viral genome in myocardial biopsies ranges from
% to 75% (maximum sample, n  20) (7–9). Conversely,
nteroviral deoxyribonucleic acid may also be present in tissue from
atients with ischemic and valvular heart disease, suggesting a
ystander role (10), while inflammation without detectable viral
enome is documented in both familial DCM (11) and arrhyth-
ogenic cardiomyopathy (7). Taken together, the contribution of
iruses to genetically determined cases seems at most subsidiary
nd at present largely speculative.
Srijita Sen-Chowdhry, MBBS, MD
etros Syrris, PhD
anjay K. Prasad, MD
iân E. Hughes, MBBS, PhD
obert Merrifield, PhD
eirdre Ward, MBBS
udley J. Pennell, MD
illiam J. McKenna, MD, DSc
University College London
nherited Cardiovascular Disease Group
he Heart Hospital
6-18 Westmoreland Street
ondon W1G 8PH
nited Kingdom
-mail: Srijita@aol.com
doi:10.1016/j.jacc.2009.01.045
EFERENCES
1. Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhyth-
mogenic cardiomyopathy: an under-recognized clinical entity. J Am
Coll Cardiol 2008;52:2175–87.
2. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E,
McKenna WJ. Clinical and genetic characterization of families
with arrhythmogenic right ventricular dysplasia/cardiomyopathy
provides novel insights into patterns of disease expression. Circu-
lation 2007;115:1710–20.
3. McKenna WJ, Thiene G, Nava A, et al., for the Task Force of the
Working Group Myocardial and Pericardial Disease of the European
Society of Cardiology and of the Scientific Council on Cardiomyopathies
of the International Society and Federation of Cardiology. F. Diagnosis of
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J
1994;71:215–8.
4. Fontaine GH, Fornès P. Letter regarding article by Norman et al,
“Novel mutation in desmoplakin causes arrhythmogenic left ventricu-
lar cardiomyopathy”. Circulation 2006;113:e68–9.
5. Yang Z, Bowles NE, Scherer SE, et al. Desmosomal dysfunction due
to mutations in desmoplakin causes arrhythmogenic right ventricular
dysplasia/cardiomyopathy. Circ Res 2006;99:646–55.
6. Diong D, Knowlton KU. Dystrophin deficiency markedly increases
enteroviral cardiomyopathy: genetic predisposition to viral heart dis-
ease. Circulation 2001;104 Suppl II:II82.
7. Calabrese F, Angelini A, Thiene G, Basso C, Nava A, Valente M. No
detection of enteroviral genome in the myocardium of patients with
arrhythmogenic right ventricular cardiomyopathy. J Clin Pathol 2000;
53:382–7.
11
1572 Correspondence JACC Vol. 53, No. 17, 2009
April 28, 2009:1569–728. Calabrese F, Basso C, Carturan E, Valente M, Thiene G. Arrhyth-
mogenic right ventricular cardiomyopathy/dysplasia: is there a role for
viruses? Cardiovasc Pathol 2006;15:11–7.
9. Bowles NE, Ni J, Marcus F, Towbin JA. The detection of cardiotropic
viruses in the myocardium of patients with arrhythmogenic right ventric-
ular dysplasia/cardiomyopathy. J Am Coll Cardiol 2002;39:892–5.0. Keeling PJ, Jeffery S, Caforio AL, et al. Similar prevalence of
enteroviral genome within the myocardium from patients with idio-
pathic dilated cardiomyopathy and controls by the polymerase chain
reaction. Br Heart J 1992;68:554–9.
1. Mahon NG, Zal B, Arno G, et al. Absence of viral nucleic acids in
early and late dilated cardiomyopathy. Heart 2001;86:687–92.
